195 related articles for article (PubMed ID: 30349893)
1. Analysis of procoagulant phosphatidylserine-exposing platelets by imaging flow cytometry.
Reddy EC; Wang H; Christensen H; McMillan-Ward E; Israels SJ; Bang KWA; Rand ML
Res Pract Thromb Haemost; 2018 Oct; 2(4):736-750. PubMed ID: 30349893
[TBL] [Abstract][Full Text] [Related]
2. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
3. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects.
Gwozdz AM; Leung R; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
Thromb Haemost; 2010 Jun; 103(6):1218-27. PubMed ID: 20352156
[TBL] [Abstract][Full Text] [Related]
4. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
Wolfs JL; Comfurius P; Rasmussen JT; Keuren JF; Lindhout T; Zwaal RF; Bevers EM
Cell Mol Life Sci; 2005 Jul; 62(13):1514-25. PubMed ID: 15971000
[TBL] [Abstract][Full Text] [Related]
5. Young steady-state rabbit platelets do not have an enhanced capacity to expose procoagulant phosphatidylserine.
Reddy EC; Wang H; Bang KWA; Packham MA; Rand ML
Platelets; 2018 Jan; 29(1):27-33. PubMed ID: 28406717
[TBL] [Abstract][Full Text] [Related]
6. Procoagulant Phosphatidylserine-Exposing Platelets
Reddy EC; Rand ML
Front Cardiovasc Med; 2020; 7():15. PubMed ID: 32195268
[TBL] [Abstract][Full Text] [Related]
7. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation.
Millington-Burgess SL; Harper MT
J Thromb Haemost; 2022 Apr; 20(4):989-995. PubMed ID: 35034417
[TBL] [Abstract][Full Text] [Related]
8. Complementary roles of platelet α
Heinzmann ACA; Karel MFA; Coenen DM; Vajen T; Meulendijks NMM; Nagy M; Suylen DPL; Cosemans JMEM; Heemskerk JWM; Hackeng TM; Koenen RR
Atherosclerosis; 2020 Oct; 310():17-25. PubMed ID: 32877806
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction.
Gasecka A; Nieuwland R; Budnik M; Dignat-George F; Eyileten C; Harrison P; Huczek Z; Kapłon-Cieślicka A; Lacroix R; Opolski G; Pluta K; van der Pol E; Postuła M; Leroyer A; Siljander P; Sturk A; Filipiak KJ
Platelets; 2020; 31(1):26-32. PubMed ID: 30585111
[TBL] [Abstract][Full Text] [Related]
10. 2-Aminoethoxydiphenylborate (2-APB) inhibits release of phosphatidylserine-exposing extracellular vesicles from platelets.
Wei H; Davies JE; Harper MT
Cell Death Discov; 2020; 6():10. PubMed ID: 32140260
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome platelets.
Rand ML; Wang H; Bang KW; Teitel JM; Blanchette VS; Freedman J; Nurden AT
Am J Hematol; 2010 Aug; 85(8):584-92. PubMed ID: 20658588
[TBL] [Abstract][Full Text] [Related]
12. Identification of platelet subpopulations in cryopreserved platelet components using multi-colour imaging flow cytometry.
Johnson L; Lei P; Waters L; Padula MP; Marks DC
Sci Rep; 2023 Jan; 13(1):1221. PubMed ID: 36681723
[TBL] [Abstract][Full Text] [Related]
13. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses.
Heemskerk JW; Vuist WM; Feijge MA; Reutelingsperger CP; Lindhout T
Blood; 1997 Oct; 90(7):2615-25. PubMed ID: 9326228
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrially mediated integrin αIIbβ3 protein inactivation limits thrombus growth.
Liu F; Gamez G; Myers DR; Clemmons W; Lam WA; Jobe SM
J Biol Chem; 2013 Oct; 288(42):30672-30681. PubMed ID: 24014035
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate inhibits release of extracellular vesicles from platelets without inhibiting phosphatidylserine exposure.
Millington-Burgess SL; Harper MT
Sci Rep; 2021 Sep; 11(1):17678. PubMed ID: 34480042
[TBL] [Abstract][Full Text] [Related]
16. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
17. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
[TBL] [Abstract][Full Text] [Related]
18. Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady-state senescence.
Rand ML; Wang H; Bang KW; Poon KS; Packham MA; Freedman J
J Thromb Haemost; 2004 Apr; 2(4):651-9. PubMed ID: 15102022
[TBL] [Abstract][Full Text] [Related]
19. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting.
Podoplelova NA; Sveshnikova AN; Kotova YN; Eckly A; Receveur N; Nechipurenko DY; Obydennyi SI; Kireev II; Gachet C; Ataullakhanov FI; Mangin PH; Panteleev MA
Blood; 2016 Sep; 128(13):1745-55. PubMed ID: 27432876
[TBL] [Abstract][Full Text] [Related]
20. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain.
Siljander P; Farndale RW; Feijge MA; Comfurius P; Kos S; Bevers EM; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):618-27. PubMed ID: 11304481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
